Clinical implications of the JAK2 V617F mutation in essential thrombocythemia.
Antonioli
E
E
Guglielmelli
P
P
Pancrazzi
A
A
Bogani
C
C
Verrucci
M
M
Ponziani
V
V
Longo
G
G
Bosi
A
A
Vannucchi
A M
AM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D053614:Janus Kinase 2; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D013920:Thrombocythemia, Essential / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics*
D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2